Literature DB >> 4298549

Immunosuppressive effects of macrophage antiserum.

J Panijel, P Cayeux.   

Abstract

Mesh：

Substances：

Year:  1968        PMID： 4298549      PMCID： PMC1409371     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  13 in total

1.  BEHAVIOUR OF ACTIVE BACTERIAL ANTIGENS DURING THE INDUCTION OF THE IMMUNE RESPONSE. I. PROPERTIES OF FLAGELLAR ANTIGENS FROM SALMONELLA.

Authors:  G L ADA; G J NOSSAL; J PYE; A ABBOT
Journal:  Nature       Date:  1963-09-28       Impact factor: 49.962

2.  IMMUNOGENICITY OF ANTIGEN-CONTAINING RIBONUCLEIC ACID PREPARATIONS FROM MACROPHAGES.

Authors:  B A ASKONAS; J M RHODES
Journal:  Nature       Date:  1965-01-30       Impact factor: 49.962

3.  Immunogenic sub-cellular particles obtained from spleens of antigen-injected mice.

Authors:  R E FRANZL
Journal:  Nature       Date:  1962-08-04       Impact factor: 49.962

4.  Immunochemistry.

Authors:  F HAUROWITZ
Journal:  Annu Rev Biochem       Date:  1960       Impact factor: 23.643

5.  The role and function of the reticulo-endothelial system in immunological processes.

Authors:  B N HALPERN
Journal:  J Pharm Pharmacol       Date:  1959-06       Impact factor: 3.765

6.  Experimental salmonellosis. Intracellular growth of Salmonella enteritidis ingested in mononuclear phagocytes of mice, and cellular basis of immunity.

Authors:  S MITSUHASHI; I SATO; T TANAKA
Journal:  J Bacteriol       Date:  1961-06       Impact factor: 3.490

7.  Discussion: recent advances in the use of tissue culture methods in virus research.

Authors:  F K SANDERS; R F SELLERS; T W PAY
Journal:  Proc R Soc Med       Date:  1957-10

8.  The pathogenesis of experimental infections with encephalomyocarditis (EMC) virus.

Authors:  L Dickinson; A J Griffiths
Journal:  Br J Exp Pathol       Date:  1966-02

9.  [Streptococcal (Streptococcus pyogenes) arthritis and cardiopathies experimentally produced in mice].

Authors:  J Panijel; P Cayeux
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1965-07-12

10.  The role of macrophages in the induction of antibody in x-irradiated animals.

Authors:  R Gallily; M Feldman
Journal:  Immunology       Date:  1967-02       Impact factor: 7.397
View more
  14 in total

Review 1.  Role of macrophages in natural resistance to virus infections.

Authors:  S C Mogensen
Journal:  Microbiol Rev       Date:  1979-03

Review 2.  Mechanisms of virus pathogenicity.

Authors:  H Smith
Journal:  Bacteriol Rev       Date:  1972-09

3.  Specificity and nature of binding of antimacrophage serum.

Authors:  R Gallily; M Gornostansky
Journal:  Immunology       Date:  1972-03       Impact factor: 7.397

4.  In vitro and in vivo studies of the properties and effects of antimacrophage sers (AMS).

Authors:  R Gallily
Journal:  Clin Exp Immunol       Date:  1971-09       Impact factor: 4.330

5.  Specific heterologous antimacrophage serum: in vitro effects, and the effect on the efferent arm of cutaneous delayed hypersensitivity.

Authors:  S B Smith; E Pont
Journal:  Blut       Date:  1972-04

6.  Effects of antimacrophage, antithymocyte, antilymphocyte and antispleen serum on the immune response in mice.

Authors:  B F Argyris; D H Plotkin
Journal:  Clin Exp Immunol       Date:  1970-10       Impact factor: 4.330

7.  Antigenic differences between macrophages and lymphocytes.

Authors:  A W Marsman; M van der Hart; J J van Loghem
Journal:  Clin Exp Immunol       Date:  1970-06       Impact factor: 4.330

8.  A study of the effects of anti-macrophage sera.

Authors:  G Loewi; A Temple; A P Nind; M Axelrad
Journal:  Immunology       Date:  1969-01       Impact factor: 7.397

9.  Studies on antimacrophage globulin.

Authors:  H E Jasin; D Lennard; M Ziff
Journal:  Clin Exp Immunol       Date:  1971-05       Impact factor: 4.330

10.  Effects of antithymocyte and antimacrophage sera on the survival of mice infected with Listeria monocytogenes.

Authors:  L D Pearson; J W Osebold
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.